Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trophic factors are a broad class of secreted proteins that play a critical role in the survival, development, and functional maintenance of various cell types, particularly within the central and peripheral nervous systems [1, 9]. The most well-characterized subgroup, the neurotrophins, includes Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Neurotrophin-3 (NT-3), all of which bind to specific receptors to activate pro-survival signaling pathways such as PI3K/Akt and MAPK/ERK [1, 4, 11]. These molecules are essential for neurogenesis and synaptic plasticity, and their dysregulation is a primary hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's, as well as psychiatric disorders like major depression [2, 3, 9, 10]. In clinical practice, therapeutic strategies range from the administration of recombinant factors like Cenergermin to small-molecule mimetics and gene therapies aimed at restoring trophic support in failing tissues [4, 8, 12]. Conversely, in oncology, the overactivity of trophic factor pathways can drive tumor progression, making their receptors significant targets for inhibitory drugs such as Trk antagonists [4, 15].
Trophic factors primarily function by binding to specific cell surface receptors, such as Tropomyosin receptor kinases (TrkA, TrkB, TrkC) and the p75 neurotrophin receptor (p75NTR) [1, 4, 6]. Upon ligand binding, these receptors undergo dimerization and autophosphorylation, initiating downstream intracellular signaling cascades including the PI3K/Akt pathway for cell survival, the Ras/MAPK/ERK pathway for growth and differentiation, and the PLC-gamma pathway for synaptic plasticity [1, 7, 11]. Certain factors also engage the p75NTR independently or as a co-receptor to modulate Trk affinity or trigger apoptotic signaling pathways in specific cellular contexts [4, 6, 7].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trophic factor (NTF).